maritide glp-1 Amgen's Once-Monthly Agonist for Obesity and Diabetes | Iftikhar GiLL posted on the topic Medscape | The investigational triple
Description
Emotional eating is a well-known contributor to weight gain due to anxiety and other mental health conditions
So far, the safety profile appears reassuring
It has since dropped to third place
hazard ratio 1.60, 95% CI 1.37 to 1.87) but not after confounding factors were accounted for (0.91, 0.73 to 1.12)
Regulatory Approvals and New Product Launches: The GLP-1 Receptor Agonist Market is significantly influenced by regulatory approvals and new product launches
